HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xianhong Shu Selected Research

human MIRN582 microRNA

1/2018hsa-miR-320d and hsa-miR-582, miRNA Biomarkers of Aortic Dissection, Regulate Apoptosis of Vascular Smooth Muscle Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xianhong Shu Research Topics

Disease

4Heart Failure
01/2021 - 12/2017
4Cardiotoxicity
03/2020 - 01/2013
4ST Elevation Myocardial Infarction
07/2013 - 06/2010
3Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
03/2020 - 01/2017
3Aortic Valve Stenosis (Aortic Stenosis)
01/2020 - 07/2013
3Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2016 - 01/2013
3Atrioventricular Block
04/2010 - 04/2009
2Bicuspid Aortic Valve Disease
04/2021 - 02/2016
2Lymphoma (Lymphomas)
05/2019 - 01/2017
2Acute Coronary Syndrome
10/2011 - 07/2011
1Genetic Predisposition to Disease (Genetic Predisposition)
04/2021
1Aortic Valve Insufficiency (Aortic Regurgitation)
04/2021
1Mitral Valve Prolapse
04/2021
1Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
03/2021
1Left Ventricular Dysfunction
03/2020
1Glycogen Storage Disease Type IIb
01/2019
1Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy)
08/2018
1Aortic Dissection
01/2018
1Bundle-Branch Block (Fascicular Block)
12/2017
1Hypertension (High Blood Pressure)
01/2017
1Hyperuricemia
01/2017
1Cardiomyopathies (Cardiomyopathy)
01/2014
1Myocardial Ischemia (Ischemic Heart Diseases)
01/2014
1Sexually Transmitted Diseases (Sexually Transmitted Disease)
01/2013
1Myocardial Infarction
06/2010
1Hemorrhage
06/2010
1Cardiac Arrhythmias (Arrythmia)
07/2009
1Atrial Fibrillation
07/2009
1Sick Sinus Syndrome
07/2009
1Bradycardia
07/2009

Drug/Important Bio-Agent (IBA)

4AnthracyclinesIBA
03/2020 - 01/2013
4Glycoproteins (Glycoprotein)IBA
07/2013 - 06/2010
3Biomarkers (Surrogate Marker)IBA
01/2018 - 10/2011
2Proteins (Proteins, Gene)FDA Link
01/2019 - 08/2018
2Epirubicin (Ellence)FDA LinkGeneric
03/2014 - 01/2013
2Peroxidase (Myeloperoxidase)IBA
10/2011 - 07/2011
2Abciximab (ReoPro)FDA Link
08/2010 - 06/2010
2Dichlorodiphenyldichloroethane (DDD)IBA
04/2010 - 04/2009
1Genetic Markers (Genetic Marker)IBA
04/2021
1N 30IBA
03/2021
1R-CHOP protocolIBA
05/2019
1GlycogenIBA
01/2019
1Dynamins (Dynamin)IBA
01/2019
1Lysosomal-Associated Membrane Protein 2IBA
01/2019
1mitochondrial calcium uniporterIBA
01/2019
1MicroRNAs (MicroRNA)IBA
01/2018
1human MIRN582 microRNAIBA
01/2018
1Uric Acid (Urate)IBA
01/2017
1Matrix Metalloproteinases (MMPs)IBA
02/2016
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2016
1Troponin T (Troponin T1)IBA
03/2014
1ThienopyridinesIBA
07/2013
1Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
04/2012
1pro-brain natriuretic peptide (1-76)IBA
07/2009
1B 43IBA
07/2009
1Brain Natriuretic Peptide (Natrecor)FDA Link
07/2009

Therapy/Procedure

5Percutaneous Coronary Intervention
07/2013 - 06/2010
4Cardiac Resynchronization Therapy
01/2021 - 01/2014
4Drug Therapy (Chemotherapy)
03/2020 - 03/2014
1Transcatheter Aortic Valve Replacement
01/2020
1Therapeutics
01/2017
1Aftercare (After-Treatment)
03/2014
1Cardiopulmonary Bypass (Heart-Lung Bypass)
07/2013
1Intravenous Administration
04/2012